Ganciclovir recalls
Ganciclovir products have been recalled 1 time, most recently on 4 Jan 2023. The recalling company is usually Hikma Pharmaceuticals USA. The most common reason is labeling errors.
Total recalls1since 2023
Last 12 months0reported
Class I00% of total
Ongoing0latest 4 Jan 2023
Recalls per month, last 24 months
click a bar for that monthSeverity split
Class I 0 0%Class II 1 100%Class III 0 0%
Why ganciclovir is recalled
Companies
Product types
By year
All ganciclovir recalls, newest first
1 total| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS II | Ganciclovir for Injection, USP, 500mg per vial recalledGanciclovir | Hikma Pharmaceuticals USA | Labeling Errors | Nationwide |
About this list
Records come from FDA enforcement reports and USDA FSIS notices, grouped by normalised name. A company operating under several names may appear more than once.